ethambutol has been researched along with Liver Dysfunction in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kedarisetty, CK; Khillan, V; Kumar, N; Kumar, S; Sarin, SK | 1 |
| Escalon, JG; Hissong, E; Kaner, RJ; Legasto, AC; Momtahen, S; O'Beirne, SL; Port, JL; Schenck, EJ | 1 |
| Adhvaryu, MR; Reddy, N; Vakharia, BC | 1 |
| Gulati, K; Ray, A; Vijayan, VK | 1 |
| Belotserkovets, VG; Ubaĭdullaev, AM | 1 |
| Conde, MB; Dorman, SE; Guerra, RL; Mello, FC; Muzy-de-Souza, GR; Szklo, A | 1 |
| Austerhoff, A; Kindler, U; Knop, P | 1 |
| Maier-borst, W; Osswald, H; Schumacher, J; Wayss, K | 1 |
| Austerhoff, A; Kindler, U; Knieriem, HJ; Knop, P | 1 |
| Menghini, P; Pozzi, E | 1 |
| Jentgens, H | 1 |
| Tousek, J | 1 |
| Rollier, F; Verbist, L | 1 |
1 review(s) available for ethambutol and Liver Dysfunction
| Article | Year |
|---|---|
Antitubercular therapy in patients with cirrhosis: challenges and options.
Topics: Antitubercular Agents; Ethambutol; Humans; Immune System Diseases; Isoniazid; Latent Tuberculosis; Liver; Liver Cirrhosis; Liver Diseases; Liver Failure; Liver Function Tests; Liver Transplantation; Prevalence; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2014 |
3 trial(s) available for ethambutol and Liver Dysfunction
| Article | Year |
|---|---|
Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.
Topics: Adult; Antitubercular Agents; Blood Sedimentation; Body Weight; Chemical and Drug Induced Liver Injury; Curcuma; Drug Therapy, Combination; Ethambutol; Female; Hemoglobins; Humans; Isoniazid; Liver Diseases; Male; Middle Aged; Patient Compliance; Plant Preparations; Pyrazinamide; Rifampin; Tinospora; Treatment Outcome; Tuberculosis | 2008 |
Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction.
Topics: Adolescent; Adult; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drug Combinations; Ethambutol; Follow-Up Studies; Humans; Liver Diseases; Liver Function Tests; Middle Aged; Phytotherapy; Plant Preparations; Plants, Medicinal; Prospective Studies; Pyrazinamide; Rifampin; Single-Blind Method; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2010 |
[Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
Topics: Administration, Oral; Antitubercular Agents; Diabetes Complications; Ethambutol; Humans; Hypoglycemic Agents; Injections, Intralymphatic; Injections, Intramuscular; Insulin; Isoniazid; Liver Diseases; Lymphatic System; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 2004 |
9 other study(ies) available for ethambutol and Liver Dysfunction
| Article | Year |
|---|---|
Severe Cavitary, Fistulating Mycobacterium avium-intracellulare Complex Disease in an Immunocompetent Host.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchial Fistula; Cysts; Ethambutol; Humans; Hydropneumothorax; Immunocompromised Host; Liver Diseases; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pleura; Rifampin; Tomography, X-Ray Computed | 2015 |
Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
Topics: Antitubercular Agents; Brazil; Cohort Studies; Comorbidity; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hospitals, Public; Humans; Liver Diseases; Liver Function Tests; Male; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis, Pulmonary; Urban Population | 2007 |
[Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
Topics: Adult; Aged; Ethambutol; Female; Humans; Isoniazid; Liver Diseases; Male; Prospective Studies; Rifampin; Time Factors; Transaminases; Tuberculosis, Pulmonary | 1977 |
Uptake and excretion of 61Cu and 64Cu-myambutol by the liver. Experimental studies in rats and possibilities of a functional liver test in humans.
Topics: Animals; Ceruloplasmin; Copper; Diethylnitrosamine; Ethambutol; Humans; Liver; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Radioisotopes; Radionuclide Imaging; Rats | 1976 |
[Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Cholestasis; Clinical Enzyme Tests; Drug Therapy, Combination; Ethambutol; Fatty Liver; Female; Humans; Isoniazid; Liver Diseases; Liver Function Tests; Male; Middle Aged; Necrosis; Rifampin; Sulfobromophthalein; Tuberculosis, Pulmonary | 1974 |
Blood levels of rifampicin in liver diseases.
Topics: Ethambutol; Humans; Isoniazid; Jaundice; Liver; Liver Diseases; Rifampin; Sulfobromophthalein; Tuberculosis, Pulmonary | 1974 |
[Antitubercular agents in hepatitis].
Topics: Antitubercular Agents; Chronic Disease; Ethambutol; Hepatitis; Humans; Liver Diseases; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
Topics: Adult; Aged; Chronic Disease; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Rifampin; Sputum; Tuberculosis, Pulmonary | 1971 |
Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations.
Topics: Alanine Transaminase; Analysis of Variance; Aspartate Aminotransferases; Bilirubin; Drug Combinations; Ethambutol; Humans; Isoniazid; Liver; Liver Diseases; Liver Function Tests; Rifampin; Time Factors | 1971 |